Study of tegoprazan for patients with GERD
Part of Digestive system clinical trials.
This study looks at how well and how safely the drug tegoprazan works for people with gastroesophageal reflux disease (GERD). It may help if you have symptoms like heartburn or acid reflux.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You have a score of 8 or more on a GERD questionnaire.
- You agree to take part and sign a consent form.
- You are not allergic to benzimidazole drugs or any part of tegoprazan.
- You are not taking medications containing atazanavir, nelfinavir, or rilpivirine.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called tegoprazan can help doctors diagnose acid reflux (GERD). Eligible participants will take the medication and track their symptoms to see if it improves them.
This trial studies how two medicines, toprazole and aspirin, interact in healthy men. You'll take both and have your blood tested to see how your body handles them.
This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.
This trial tests a treatment for nighttime heartburn caused by GERD, a condition where stomach acid damages the esophagus. It is for adults who have had nighttime heartburn for more than 3 months and have been diagnosed with erosive GERD.
This trial compares two different types of stomach-acid-lowering medicines — tegoprazan and a proton pump inhibitor (PPI) — to see which works better at clearing H. pylori infection. It's for people who have not been treated for H. pylori before and can safely have a stomach scope.
This trial tests whether a stomach-acid-reducing drug (tegoprazan) helps prevent complications during planned surgeries under general anesthesia. It is for adults aged 20–69 with a non-emergency surgery and a BMI under 35.
Hear when a new GERD (Gastroesophageal Reflux Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.